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CC BY-NC-ND license (http://creativBackground/Purpose: To investigate the feasibility, effectiveness, and complications of
catheter-directed thrombolysis (CDT) using three different approaches for acute lower-
extremity deep venous thrombosis (DVT).
Methods: A total of 106 patients with acute DVTwere enrolled in this study. Forty-one patients
received CDT through the small saphenous vein (Group A), 35 through the great saphenous vein
(Group B), and 30 through the popliteal vein (Group C). Iliac vein balloon dilation and stenting
was performed in 65 cases.
Results: The vascular approach route was not statistically related to limb edema reduction
rates (Groups A, B, and C: 82.3  7.6% vs. 81.6  6.0% vs. 83.9  6.1%), nor to thrombolysis
rates (63.5  7.7% vs. 66.9  8.4% vs. 66.1  2.7%). The procedure was significantly shorter
for Groups B and C. No significant difference was found between Groups B and C. Most compli-
cations occurred in Group A. The complication rate in Group B was the lowest. Eighty-eight pa-
tients were followed up for 7e24 months. Of these, 78 were pain-free and without limb
edema; six showed rethrombosis.
Conclusion: CDT is an effective method to manage acute DVT. Of the three routes tested, the
small saphenous vein route was associated with more frequent complications. Great saphenous
vein catheterization was more effective because of its lower complication rate.
Copyright ª 2015, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
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Catheter-directed thrombolysis for DVT 653IntroductionDeep venous thrombosis (DVT) is commonly associated with
vascular surgery, but there are very many other causes. Mil-
lions of patients are at risk of developing DVT, and it is esti-
mated that> 250,000 new cases occur every year. Pulmonary
embolus is themost serious complication ofDVT, and> 50,000
patients die every year as a result of pulmonary embolus.1
Even when DVT is diagnosed expeditiously, many patients
are inadequately treated and experience a 20e50% recur-
rence rate. Furthermore,w30% of patients who develop DVT
experience life-long post-thrombotic syndrome.2
In addition to the acute risks of DVT, there are important
long-term complications. Thrombus can cause valvular
incompetence and luminal obstruction, which can ulti-
mately lead to chronic deep venous insufficiency and
chronic venous disease, such as chronic varicose ulceration,
hyperpigmentation, pain, and edema, all of which repre-
sent a significant socioeconomic burden.3 The main long-
term goal of treatment for DVT is to prevent chronic deep
venous insufficiency. Therefore, although the patency of
the thrombolysed vein is of relevance, the venous valve
function may be at least as important.
Thrombolytic agents may be delivered by systemic
infusion, local-regional administration, or catheter-
directed therapy. Systemic administration is associated
with long infusion times, a high incidence of partial
thrombolysis, and a significant rate of bleeding complica-
tions. In catheter-directed thrombolytic therapy (CDT), the
tip of the catheter is placed inside the thrombus and the
thrombolytic agent is administered directly therein. It is
hoped that CDT preserves venous valves, thus restoring flow
in the deep venous system and minimizing the long-term
complications of DVT.4 To date, the approaches for CDT
reported in the literature include the right jugular vein,
contralateral femoral vein, popliteal vein, great saphenous
vein, and small saphenous vein. The popliteal vein is the
choice in most procedures for catheterization; in our
experience, however, this approach may not be possible in
some patients. It is also important to review techniques to
identify the safest and most effective approaches.
In this study, we reviewed the records of 106 patients
admitted to our hospital with acute lower-extremity DVT
who were treated with CDT using different access routes,
including the small saphenous vein, great saphenous vein,
and popliteal vein, between September 2011 and November
2013.
Methods
Ethics approval
This study was reviewed and approved by the Ethics Com-
mittee of the First Affiliated Hospital of Soo Chow Univer-
sity, Suzhou, China (File No: 2011270).
Study groups
Between September 2011 and November 2013, 126 pa-
tients with extensive acute lower-extremity DVT were
initially enrolled into this study and were randomized intothree groups (Figure 1). Twenty patients were excluded
from this study because of high blood pressure, throm-
bocytopenia, limb infection, or cardiac insufficiency,
leaving 106 patients. Demographic information collected
included age, sex, cause of DVT, duration of DVT before
admission and which extremity was involved. Presenting
symptoms included limb pain, phlegmasia, and edema. All
patients were confirmed to have DVT by conventional
venography before CDT, and only patients with extensive
thrombosis including the femoropopliteal vein and iliac
vein were recruited. All patients were randomly allocated
to one of three groups. Randomization was determined
sequentially, i.e., since the presentation of patients to
the hospital is effectively random, procedures were allo-
cated according to the previous allocation. Patient 1
received Procedure A, Patient 2 received Procedure B,
Patient 3 received Procedure C, Patient 4 received Pro-
cedure A, etc. Groups AeC underwent catheterization via
the small saphenous vein, the great saphenous vein and
the popliteal vein, respectively. Of the 20 patients
excluded from this study, there were one patient, seven
patients, and 12 patients excluded from Groups A, B, and
C, respectively. The group size was determined by the
study duration, i.e. the study was planned to be carried
out over 2 years, which meant that w100 patients would
be recruited during the period, based on previous expe-
rience of serious DVT incidence.
Prior to CDT, all patients were evaluated by the same
member of the operation team to confirm their suitability
for thrombolysis therapy. The inclusion criteria were:
acute lower-extremity DVT (symptoms lasting < 14 days);
extensive DVT (including iliac, femoral, and popliteal
veins); age 15e75 years; thrombosis confirmed by anter-
ograde venography using the dorsal vein; and informed
signed consent by the patient to participate. The exclu-
sion criteria were: contraindications to the use of anti-
coagulant drugs, thrombolytic drugs or intravenous
contrast media; history of intracranial or internal hem-
orrhage in the previous 3 months; history of serious
trauma or major operation in the preceding 4 weeks;
pregnancy; high blood pressure (systolic blood pressure
>180 mmHg, diastolic blood pressure >110 mmHg); and
history of ipsilateral DVT.
Safety
For safety, the first procedure was to insert a retrievable
filter into the inferior vena cava. If the temporary filter was
free of thrombus, it was removed; otherwise, the filter was
implanted permanently.
Catheter implantation
(1) Catheterization through the small saphenous vein:
Patients were placed prone on the angiographic
table, and a longitudinal incision of approximately
2 cm was made between the ipsilateral external
malleolus and the Achilles tendon to expose the
small saphenous vein. A 5F sheath was inserted,
through which all subsequent catheter and wire
exchanges were performed. Under the guidance of
Figure 1 CONSORT 2010 flow diagram.
654 P.-F. Duan, C.-F. Nian elbowed catheter, a hydrophilic guide wire was
navigated through the small saphenous vein to the
popliteal vein and to the IVC. Then, a multiple-side-
hole 5F coaxial catheter (UniFuse; Angiodynamics,
Queensbury, NY, USA) was exchanged. Using a 50-cm
catheter, the tip was placed at the iliocaval
junction.
(2) Catheterization through the great saphenous vein:
Patients were placed in the same position as they
would be placed for IVC filter insertion. After
puncture, a 5F sheath was inserted into the great
saphenous vein with the guidance of ultrasound, and
a guidewire was inserted into the popliteal vein via
communicating branches between the superficial
and deep venous system, assisted by a road map
resulting from venography performed via the
sheath.
(3) Catheterization through the popliteal vein: With the
patient prone on the angiographic table, the popliteal
vein was accessed under ultrasonographic guidance
with a small-gauge echogenic needle to avoid inad-
vertent puncture of the adjacent popliteal artery. A
5F sheath was inserted, and catheterization was
performed as described previously for the small
saphenous vein.Thrombolysis
In all cases, thrombolysis was carried out using urokinase.
Infusion was performed through the coaxial catheter at an
even speed with a total dose of 10,000 units/kg/24 h. Low-
molecular-weight heparin was administered systemically
during the procedure and after lysis. Lysis progression was
monitored with daily venography. Thrombolysis was termi-
nated if no additional lysis was achieved in the preceding 24
hours or there was a fibrinogen level < 1.0 g/L. Throm-
bolysis was discontinued after 5e7 days. Laboratory tests,
including hematocrit, prothrombin time, activated partial
thromboplastin time, and international normalized ratio
(INR), were determined before and after lysis and
throughout the patient’s hospital stay.Adjunctive treatment of iliac lesions
Self-expandable metallic stents (Bard Luminexx,
14 mm  80 mm) were used to treat lesions that had been
obscured by thrombus but were “uncovered” after throm-
bolysis, particularly stenoses and/or short occlusions at the
level of the iliac veins. Some of these lesions may represent
cases of MayeThurner syndrome, in which the left iliac vein
is compressed by the right iliac artery. The diameter of the
Catheter-directed thrombolysis for DVT 655percutaneous transluminal angioplasty balloon was
selected to match the size of the vein adjacent to the
lesion while the stent was measured to be 2 mm oversized,
and the length to cover the stenotic segment was measured
to include a 2-cm margin.
Post-thrombolysis therapy
Warfarin administration was routinely started prior to hos-
pital discharge and was recommended to continue for at
least 6 months. The INR target for post-thrombolysis ther-
apy was 2.0e3.0. In addition, the patients were recom-
mended to wear elastic stockings.
Evaluation
The percentage detumescence (ratio between pre- and
postlysis thigh perimeter difference to prelysis thigh
perimeter difference) was calculated. Circumferences
were measured 20 cm above the knee.% detumescenceZ
Pretreatment thigh difference post-treatment thigh difference
Pretreatment thigh difference
 100% ð1ÞVenograms were reviewed, scored and graded for each
infusion using a modification of the reporting standards for
venous disease described by Porter and Moneta.5 A thrombus
score was calculated for seven venous segments: the IVC, the
common iliac vein, the external iliac vein, the common
femoral vein, the proximal portion of the superficial femoral
vein, the distal portion of the superficial femoral vein, and the
popliteal vein. The thrombus score was 0 when the vein was
patent and completely free of thrombus, 1 for partial occlu-
sion, and 2 for complete occlusion. The total thrombus score
before and after lysis was calculated by adding the scores of
the seven venous segments before and after completion of
treatment, which included lysis and any additional adjunctive
procedures, such as stenting. The percentage of thrombolysis
(the ratio of the difference between the pre- and postlysis
scores with prelysis scores) was calculated.
Statistical analysis
All data were collected in a database (Access version 2;
Microsoft) and analyzed with SPSS 13.0 (SPSS Inc., Chicago,
IL, USA). Continuous variables were presented as
mean  standard deviation (SD) and compared by the F
test, whereas categorical variables were analyzed by the
Chi-square test. A p value < 0.05 was used as a threshold
for statistical significance.
Follow-up
Symptomatic improvement and the overall mid-term
thrombolytic patency rate assessed by venography at 6months, 12 months, and 24 months through venography
performed by the same operative team were recorded for
all patients.
Results
Study patients
There were no deaths or symptomatic pulmonary embo-
lisms among the patients in this study. The demographic
data are presented in Table 1. DVT developed after
abdominal or pelvic operations in 23 cases and after bone or
joint operations in 21 cases. All operations had been per-
formed at least 1 month before the patients underwent
CDT. There were 15 cases of malignancy. The remainder
were without obvious causes. Stenosis of common iliac
veins with or without collateral circulation was found in 69
cases, according to the venograms taken during the CDT.
Stenoses were all located at the iliocaval junction.
TreatmentThree retrievable filters were placed permanently because
a residual thrombus was found below the filter by venog-
raphy, including two of the filters in Group A and one in
Group C. Adjunctive treatment with metallic stent place-
ment was necessary to treat uncovered stenoses and/or
short residual occlusions in 65 cases (24 cases in Group A, 22
cases in Group B, and 19 cases in Group C, respectively).
Four patients refused iliac stenting, including two in Group
A, one in Group B, and one in Group C. All procedures were
performed in the left common iliac segments. There was no
significant difference in the requirement for stenting be-
tween groups (A vs. B: c2 Z 0.148, p Z 0.701; A vs. C:
c2 Z 0.167, p Z 0.683; and B vs. C: c2 Z 0.002,
p Z 0.968).
Assessment of thrombolysis
There was no difference in the effectiveness of the pro-
cedure between the three groups according to the F-test.
The time taken in Groups B and C was tested using the F-
test and was significantly less than that in Group A
(p Z 0.007 and p Z 0.013, respectively). No significant
difference was found between Groups B and C (Table 2).
Complications
There were no major bleeding complications in the three
groups. In Group A, minor bleeding events were recorded in
four cases at the external ankle incisions, and the lowest
concentration of fibrinogen was 0.3 g/L with a urokinase
dose of 0.8 million IU/d. These four patients with minor
Table 1 Patient demographics.
Group n Mean age (y) Limb Duration, mean  SD (range) Approach
Male Female Left Right
A 18 23 65 (28e73) 35 6 110  70 h
(12 h to 10 d)
Small saphenous vein
B 19 16 63 (28e70) 30 5 108  67 h
(10 h to 11 d)
Great saphenous vein
C 12 18 66 (21e71) 28 2 107  66 h
(11 h to 12 d)
Popliteal vein
SD Z standard deviation.
Table 2 Catheter-directed thrombolysis through three different approaches.a
Group TFC (min) Clinical effect PD (%) Venography evaluation PT (%) Complications
Prelysis
TPD (cm)
Postlysis
TPD (cm)
Prelysis
Score
Postlysis
score
A 13.5  1.2 6.9  2.1 1.2  1.1 82.3  7.6a 9.0  2.6 3.3  1.3 63.5  7.7d 7
B 4.9  0.2 5.8  0.9 1.1  0.7 81.6  6.0b 7.9  2.2 2.6  1.5 66.9  8.4e 0
C 5.6  0.6 7.1  1.9 1.3  0.9 83.9  6.1c 8.5  1.9 2.7  0.9 66.1  2.7f 2
PD Z percentage of detumescence; PT Z percentage of thrombolysis; TFC Z time taken for catheterization; TPD Z thigh perimeter
difference.
a “a” compared with “b”, p Z 0.709; “a” compared with “c”, p Z 0.523; “b” compared with “c”, p Z 0.436; “d” compared with e,
p Z 0.060; d compared with f, p Z 0.311; “e” compared with f, p Z 0.803.
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heparin mixed with 500 mL of saline) at a rate of 2 mL/h for
24 hours to prevent thrombosis in the catheter. After
bleeding ceased and the fibrinogen concentration recov-
ered to > 1.0 g/L, the dose of urokinase was reduced to
8000 IU/kg/d. In one patient, phlebitis was recorded after
catheterization. These symptoms disappeared after
regional warm compress treatment with 50% salamarum for
5 days without catheter removal. Peri-incisional anesthesia
was recorded in two patients due to saphenous nerve injury
during exposure of the small saphenous vein. In Group B, no
complications were recorded. In Group C, swelling and pain
were recorded in two patients at the puncture site after
extubation. Hematoma fluid was confirmed by color ultra-
sound. These hematomas were self-absorbed at review 2
months later. The complication rate of Group B was lower
than those of the other two groups (c2Z 6.404, pZ 0.011
and c2 Z 5.001, p Z 0.025).
Follow-up
Eighteen patients were lost to follow-up because of lost
contact. The remaining 88 patients (88/106) were followed
up with venography; the median time post-CDT for the
follow-up examination was 11.1  1.3 months (range, 7e24
months). Seventy-eight patients had no symptoms
(swelling, pain) at the follow-up, and five patients had mild
edema, but their symptoms could be relieved by rest; in
addition, there were five patients who had no symptom
relief. Venography was used at follow-up, and complete
patency was found in 70 patients with normal valve func-
tion. Partial patency was found in 12 patients, and
rethrombosis was found in six patients. Four of the six casesof rethrombosis occurred within 2e3 months after CDT due
to iliac vein stenoses without stent placement; whilst the
other two rethrombosed at 3e5 months after CDT, probably
due to premature cessation of warfarin therapy. The three
filters were converted to the permanent type because a
residual thrombus was found to be partially patent without
IVC occlusion.
Discussion
CDT is an interventional thrombolysis method in which the
tip of the catheter is placed inside the thrombus. Thus, the
thrombolytic agent is administered directly into the
thrombus. This method is considered to result in a higher
rate of complete early opening of occluded veins than has
been reported with systemic or local-regional administra-
tion of thrombolytic agents.6 The catheter used to treat
this patient group was a coaxial catheter with a multiple
side-hole system. The tip of the catheter is blocked by a
steel-wire with a dilatation head during infusion, allowing
urokinase to be sprayed through the side holes, delivering
directed thrombolysis.
Venous access sites reported for thrombolysis have
included the right jugular vein, contralateral common
femoral vein, popliteal vein, and small saphenous vein.
Antegrade approaches such as catheterization from the
saphenous vein and popliteal vein are generally used and
can reduce the resistance due to valves and reduce the risk
of mechanical damage to valve leaflets caused by the
catheter and guide wire during retrograde catheteriza-
tion.7,8 A further advantage of antegrade catheterization is
that chronic lesions are often encountered at the iliocaval
junction, even in patients with acute DVT, which cannot
Catheter-directed thrombolysis for DVT 657predictably be traversed with a cephalic approach from the
right internal jugular vein or the contralateral femoral vein.
However, CDT through antegrade approaches such as the
small saphenous vein or popliteal vein also has some dis-
advantages, such as patients needing to change from a
dorsal to a prone position between filter placement and
catheterization. We noted that some elderly patients and
also those who had received lumbar spine or joint opera-
tions found it difficult to change position. Also, complica-
tions due to small saphenous vein exposure in a swollen
limb may cause injury of the concomitant saphenous nerve.
It was also important to avoid inadvertent puncture of the
adjacent popliteal artery and nerve when the patient was
randomized to the popliteal vein approach. This was a risk
even under ultrasonographic guidance.9
Therefore, we felt the best approach might be the great
saphenous vein, which we adopted for 35 patients. The
great saphenous vein is initiated at the dorsal venous arch
of the foot. It is superficial at the location of the internal
medial malleolus. Thus, the operator could perform cath-
eterization without incision or ultrasound guidance, and
patients were not required to change position after IVC
filter placement. Punctures at this site have the benefits of
a low bleeding complication rate and convenient nursing
care. However, the great saphenous vein does not join the
popliteal vein anatomically; therefore, a communicating
branch between the ipsilateral great saphenous vein and
popliteal vein must be identified by venography and cath-
eterization must be performed under road map guidance.
This procedure requires a tight tourniquet at the location
below the knee to help reveal a suitable course.
The effect of lesions at the left common iliac vein on
DVT have been extensively studied. It has been shown that
it is not sufficient simply to remove the thrombus and leave
the iliac lesion alone. In this study group, 69 patients out of
106 (65.1%) had a complicated left common iliac vein ste-
nosis. These lesions were always located at the iliocaval
junction, and the frequency was comparable to other re-
ports.10 Li et al11 treated nonthrombosed iliac vein steno-
sis/occlusion with stent placement and reported a patency
rate of 94.6% in a 3-year follow-up study. This result veri-
fied that metallic stents are safe for the treatment of iliac
vein lesions. In addition, Hood and Alexander12 reported 99
patients who received iliac vein stent placement out of 473
with DVT and found that the 1-year patency rate was 74%
with stent placement and 53% without (p < 0.01). This
result verified that stenting is necessary for the treatment
of iliac lesions complicated with DVT. However, operators
should be careful when the stenosis of the iliac vein is <
50% after balloon dilatation, as stents always exceed the
contralateral iliac vein by w1e2 mm to dilate the stenosis
located at the iliocaval junction, which can result in an
adverse effect on the venous flow of the contralateral ex-
tremity and may also increase the rate of thrombosis
recurrence caused by the rough surface of the metallic
stents themselves, although the risk of this can be reduced
by stenting the contralateral side to retail balanced flow.
A weakness of this study is that the follow-up duration
was not sufficient to demonstrate to what degree the rate
of post-thrombotic syndrome was reduced in the three
groups and even whether there were differences between
the three groups. However, the results of any early lysis andcomplete early lysis have been consistently higher in
several investigations using CDT therapy.13,14 The preva-
lence of post-thrombotic syndrome is also consistently
lower than that with other forms of administration.14,15
In conclusion, CDT with iliac venous intervention is an
effective method for the treatment of acute DVT. Choosing
the great saphenous vein as an approach made this method
easier, with fewer complications.
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